Aquestive Therapeutics, Inc. Common Stock

AQST XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

490M

Short interest (May 15)

12.1%

Net Short (Jun 03 ): -0.1%

Borrow Fee

1.13%

↑ 3.9%

Available Shares

200K

↓ 58.1%

Price Chart

Company Overview

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001398733

Asset Type: CS

Market Data

Market Cap: $493,018,967

Employees: 147

Status: Active

Short Interest

Current Borrow Fee 1.13%

Range: 0.83% - 1.31%

Available Shares 200K

Range: 15K - 700K

Recent Changes

Fee Change: ↓ 17.6%

Available Change: ↓ 10.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime